OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis
Le Yang, Shi Yue, Lin Yang, et al.
Journal of Hepatology (2013) Vol. 59, Iss. 1, pp. 114-123
Closed Access | Times Cited: 110

Showing 26-50 of 110 citing articles:

Metabolic Reprogramming of Liver Fibrosis
M. Eugenia Delgado, Beatriz Cárdenas, Núria Farran, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3604-3604
Open Access | Times Cited: 45

Targeting long non-coding RNAs in cancer therapy using CRISPR-Cas9 technology: A novel paradigm for precision oncology
Rahul Kumar Mahato, Srinjan Bhattacharya, Naina Khullar, et al.
Journal of Biotechnology (2023) Vol. 379, pp. 98-119
Closed Access | Times Cited: 17

Critical Roles of the Sphingolipid Metabolic Pathway in Liver Regeneration, Hepatocellular Carcinoma Progression and Therapy
Hiroyuki Nojima, Hiroaki Shimizu, Takashi Murakami, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 850-850
Open Access | Times Cited: 8

The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis
Er‐Jin Wang, Xingxuan He, Ming Zeng
Frontiers in Pharmacology (2019) Vol. 9
Open Access | Times Cited: 54

RETRACTED: Inhibition of the SphK1/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells
Bárbara González‐Fernández, Diana I. Sánchez, Irene Crespo, et al.
BioFactors (2016) Vol. 43, Iss. 2, pp. 272-282
Open Access | Times Cited: 52

Angiogenesis-related non-coding RNAs and gastrointestinal cancer
Zahra Razavi, Kasra Asgarpour, Maryam Mahjoubin‐Tehran, et al.
Molecular Therapy — Oncolytics (2021) Vol. 21, pp. 220-241
Open Access | Times Cited: 41

NLRP3 inflammasome priming and activation in cholestatic liver injury via the sphingosine 1-phosphate/S1P receptor 2/Gα(12/13)/MAPK signaling pathway
Lei Hou, Zhang Zhi, Le Yang, et al.
Journal of Molecular Medicine (2021) Vol. 99, Iss. 2, pp. 273-288
Closed Access | Times Cited: 37

Sphingosine 1-Phosphate Receptor 4 Promotes Nonalcoholic Steatohepatitis by Activating NLRP3 Inflammasome
Chung Hwan Hong, Myoung Seok Ko, Jae Hyun Kim, et al.
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 13, Iss. 3, pp. 925-947
Open Access | Times Cited: 34

Therapeutic potential of the sphingosine kinase 1 inhibitor, PF-543
Xueliang Yi, Xuemei Tang, Tianlong Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114401-114401
Open Access | Times Cited: 14

ROS-responsive injectable hydrogels loaded with exosomes carrying miR-4500 reverse liver fibrosis
Huili Yang, Wanshun Wang, Jiacong Xiao, et al.
Biomaterials (2024) Vol. 314, pp. 122887-122887
Closed Access | Times Cited: 5

MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA
Zhanping Lu, Weiying Zhang, Shan Gao, et al.
Biochemical and Biophysical Research Communications (2015) Vol. 468, Iss. 1-2, pp. 8-13
Closed Access | Times Cited: 48

Sphingosine kinase 1 protects renal tubular epithelial cells from renal fibrosis via induction of autophagy
Chunyang Du, Yunzhuo Ren, Fang Yao, et al.
The International Journal of Biochemistry & Cell Biology (2017) Vol. 90, pp. 17-28
Closed Access | Times Cited: 46

Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease
Burkhard Kleuser
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 3, pp. 722-722
Open Access | Times Cited: 41

The role of the sphingolipid pathway in liver fibrosis: an emerging new potential target for novel therapies
Yuval Ishay, Dean Nachman, Tawfik Khoury, et al.
AJP Cell Physiology (2020) Vol. 318, Iss. 6, pp. C1055-C1064
Closed Access | Times Cited: 34

Sphingosine kinase 1/sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 pathway: A novel target of geniposide to inhibit angiogenesis
Ming‐Hui Sun, Ran Deng, Yan Wang, et al.
Life Sciences (2020) Vol. 256, pp. 117988-117988
Closed Access | Times Cited: 34

Review article: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis ‐ a unique therapeutic target in inflammatory bowel disease
Jie Wang, Idan Goren, Bo Yang, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 55, Iss. 3, pp. 277-291
Open Access | Times Cited: 30

Intracellular Sphingosine 1-Phosphate Contributes to Collagen Expression of Hepatic Myofibroblasts in Human Liver Fibrosis Independent of Its Receptors
Lei Xiu, Na Chang, Le Yang, et al.
American Journal Of Pathology (2014) Vol. 185, Iss. 2, pp. 387-398
Open Access | Times Cited: 41

Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity
Elizabeth S. Childress, Yugesh Kharel, Anne M. Brown, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 9, pp. 3933-3957
Open Access | Times Cited: 39

Transforming growth factor-β-sphingosine kinase 1/S1P signaling upregulates microRNA-21 to promote fibrosis in renal tubular epithelial cells
Xiujuan Liu, Quan Hong, Zhen Wang, et al.
Experimental Biology and Medicine (2015) Vol. 241, Iss. 3, pp. 265-272
Open Access | Times Cited: 37

Role of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Axis in Hepatocellular Carcinoma
Michael Maceyka, Timothy D. Rohrbach, Sheldon Milstien, et al.
Handbook of experimental pharmacology (2019), pp. 3-17
Open Access | Times Cited: 32

Ceramide and Sphingosine 1-Phosphate in Liver Diseases.
Woo‐Jae Park, Jaehwi Song, Goon‐Tae Kim, et al.
PubMed (2020) Vol. 43, Iss. 5, pp. 419-430
Closed Access | Times Cited: 32

Role of sphingosine 1-phosphate signalling in tissue fibrosis
Chiara Donati, Francesca Cencetti, Caterina Bernacchioni, et al.
Cellular Signalling (2020) Vol. 78, pp. 109861-109861
Closed Access | Times Cited: 30

Sphingosine-1-phosphate receptor 3 signaling
Qian Li, Yi Li, Lei Cai, et al.
Clinica Chimica Acta (2021) Vol. 519, pp. 32-39
Closed Access | Times Cited: 25

Liver sinusoidal endothelial S1pr2 regulates experimental liver fibrosis through YAP/TGF‐β signaling pathway
Yang Liao, Caixia Zhou, Yunhao Duan, et al.
The FASEB Journal (2023) Vol. 37, Iss. 5
Open Access | Times Cited: 10

S1P/S1PR2 promote pancreatic stellate cell activation and pancreatic fibrosis in chronic pancreatitis by regulating autophagy and the NLRP3 inflammasome
Lihua Cui, Caixia Li, Guixian Zhang, et al.
Chemico-Biological Interactions (2023) Vol. 380, pp. 110541-110541
Closed Access | Times Cited: 10

Scroll to top